4//SEC Filing
Zojwalla Naseem 4
Accession 0001415889-23-015993
CIK 0001750284other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:30 PM ET
Size
14.3 KB
Accession
0001415889-23-015993
Insider Transaction Report
Form 4
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-12-06$7.02/sh+13,100$91,962→ 43,764 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-06−13,100→ 236,900 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (13,100 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001905871
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 8:30 PM ET
- Size
- 14.3 KB